Thecombination of RXR ligand with ciglitazone also cooperatively inhibits thegrowth of breast cancer and lung cancer cells by activating the RARE promoteractivity and inducing RARβ,which plays a critical role in mediating the growth-inhibitory effects ofretinoids in various cancer cells [57]. The gene discussed is RARB; the disease is cancer.